1. Home
  2. AUUD vs NXTS Comparison

AUUD vs NXTS Comparison

Compare AUUD & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auddia Inc.

AUUD

Auddia Inc.

N/A

Current Price

$1.69

Market Cap

4.2M

Sector

Technology

ML Signal

N/A

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$5.56

Market Cap

3.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
AUUD
NXTS
Founded
2012
2009
Country
United States
Israel
Employees
5
9
Industry
Computer Software: Prepackaged Software
Agricultural Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AUUD
NXTS
Price
$1.69
$5.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.1M
40.9K
Earning Date
05-11-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.55
52 Week High
$10.10
$6.75

Technical Indicators

Market Signals
Indicator
AUUD
NXTS
Relative Strength Index (RSI) 49.08 54.12
Support Level $0.74 $3.97
Resistance Level $1.95 $5.31
Average True Range (ATR) 0.28 0.71
MACD 0.04 -0.03
Stochastic Oscillator 33.60 38.28

Price Performance

Historical Comparison
AUUD
NXTS

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: